Identification of GSK625433: A novel clinical candidate for the treatment of hepatitis C.

David Haigh, E.M. Amphlett, G.S. Bravi, H. Bright, V. Chung, C.L. Chambers, A.G. Cheasty, M.A. Convery, M.R. Ellis, R. Fenwick, D.F. Gray, C.D. Hartley, P.D. Howes, R.L. Jarvest, K.J. Medhurst, A. Mehbob, D. Mesogiti, F. Mirzai, F. Nerozzi, N.R. ParryN. Roughley, T. Skarzynski, M.J. Slater, S.A. Smith, R. Stocker, C.J. Theobald, P.J. Thomas, P.A. Thommes, J.H. Thorpe, C.S. Wilkinson, E. Williams

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Identification of GSK625433: A novel clinical candidate for the treatment of hepatitis C.'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology